Natriuretic peptides, ejection fraction, and prognosis: Parsing the phenotypes of heart failure

Journal of the American College of Cardiology

Volumn 61, Issue 14, 2013, Pages 1507-1509

  Januzzi, James L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

heart failure; natriuretic peptides; preserved ejection fraction; prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

CARDIOVASCULAR RISK; DISEASE MARKER; DISEASE SEVERITY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; NOTE; PATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 84875785014     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.01.039     Document Type: Editorial

References (9)

1. J.L. Januzzi Jr., S. Rehman, T. Mueller, R.R. van Kimmenade, D.M. Lloyd-Jones Importance of biomarkers for long-term mortality prediction in acutely dyspneic patients Clin Chem 56 2010 1814 1821
2. J.L. Januzzi Jr., R. Sakhuja, M. O'Donoghue Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department Arch Intern Med 166 2006 315 320
3. A.A. Chen, M.J. Wood, D.G. Krauser NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy Eur Heart J 27 2006 839 845
4. M. O'Donoghue, A. Chen, A.L. Baggish The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study J Card Fail 11 2005 S9 S14
5. D.J. van Veldhuisen, G.C.M. Linssen, T. Jaarsma B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J Am Coll Cardiol 61 2013 1498 1506
6. J.G. Cleland, J. Taylor, N. Freemantle, K.M. Goode, A.S. Rigby, M. Tendera Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study Eur J Heart Fail 14 2012 487 494
7. I.S. Anand, T.S. Rector, J.G. Cleland Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial Circ Heart Fail 4 2011 569 577
8. J.L. Januzzi Jr., S.U. Rehman, A.A. Mohammed Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 2011 1881 1889
9. S.D. Solomon, M. Zile, B. Pieske PARAMOUNT Investigators The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial Lancet 380 2012 1387 1395